A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above
Clinical trial NCT05365724 · UNKNOWN
Trial details
- NCT number
- NCT05365724
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-10-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.